Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, has called on innovators in Africa to adopt viable business models for their enterprises to ensure growth and sustainability.
Speaking during a two-day training workshop for social entrepreneurs Eduardo Lioy, Director Corporate Strategy Development at Boehringer Ingelheim said the firm has invested heavily in training innovators and social entrepreneurs especially in human and animal health in an effort to tackle unmet human and animal health needs.